Kv1.5 potassium channel inhibitors

Details for Australian Patent Application No. 2007260984 (hide)

Owner Wyeth

Inventors Fluxe, Andrew J.; Wu, Shengde; Lee, Wenlin; Janusz, John Michael; Ridgeway II, James M.; Fairweather, Neil T.; Blass, Benjamin E.; Hodson, Stephen J.

Agent Davies Collison Cave

Pub. Number AU-A-2007260984

PCT Pub. Number WO2007/149873

Priority 60/815,066 20.06.06 US

Filing date 19 June 2007

Wipo publication date 27 December 2007

International Classifications

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/505 (2006.01) - Pyrimidines

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/149873 Priority application(s): WO2007/149873

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260985-Imidazolidinone Kv1.5 potassium channel inhibitors

2007260971-Segmented pharmaceutical dosage forms